# Cyclophosphamide for Acute Exacerbation of Idiopathic Pulmonary Fibrosis

> **NCT02460588** · PHASE3 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 120 (actual)

## Conditions studied

- Idiopathic Pulmonary Fibrosis

## Interventions

- **DRUG:** Cyclophosphamide
- **DRUG:** Placebo
- **DRUG:** Corticosteroid (prednisolone)

## Key facts

- **NCT ID:** NCT02460588
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2019-01
- **Final completion:** 2019-07
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2022-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02460588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02460588, "Cyclophosphamide for Acute Exacerbation of Idiopathic Pulmonary Fibrosis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02460588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*